Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300025
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,699
Award facts
- Contract value 100% obligated
- $19,699.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
Qiagen, LLC, a subsidiary of Qiagen N.V., was awarded a Blanket Purchase Agreement (BPA) call valued at $19,699.20 for drugs and biologicals on November 13, 2015, with an ultimate completion date of April 30, 2016. This contract, executed without a set-aside designation, reflects Qiagen's ability to compete effectively in the open federal marketplace. The work will be performed in Valencia, California. Qiagen, headquartered in Germantown, Maryland, is a foreign-owned, for-profit manufacturer specializing in molecular diagnostics, scientific equipment, and bioinformatics solutions. As a recognized provider of sample and assay technologies, the company supplies a comprehensive portfolio of products including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and diagnostic testing reagents to multiple federal agencies.
This contract call is structured as a firm fixed-price procurement under an existing BPA vehicle, demonstrating Qiagen's established relationship with the funding civilian agency. The company's federal contract portfolio includes significant work with the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense, and Federal Bureau of Investigation, where it provides specialized laboratory instrumentation such as QIAcube and QIAsymphony platforms, along with reagents, consumables, and maintenance services. Qiagen holds several notable indefinite delivery vehicles across federal agencies, including a $2.5 million contract with the FBI, a $6.5 million BPA with the Defense Health Agency, and a $10 million BPA with the National Institute of Environmental Health Sciences, positioning the company as a key supplier of molecular diagnostics products and services to the federal government.
Quick answers
Who was awarded contract HHSN26300025?
HHSN26300025 was awarded to Qiagen, LLC by Office of the Director (National Institutes of Health) on November 13, 2015.
How much is contract HHSN26300025 worth?
The government has obligated $19,699 on HHSN26300025.
Is contract HHSN26300025 an order under another contract?
Yes. HHSN26300025 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract HHSN26300025 competed?
The extent of competition for HHSN26300025 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award